Remove solutions clinical-endpoints
article thumbnail

US FDA approves Bausch + Lomb and Novaliq’s DED treatment Miebo

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval to Bausch + Lomb and Novaliq’s Miebo (perfluorohexyloctane ophthalmic solution) to treat the signs and symptoms of dry eye disease (DED). The findings showed that Miebo met its primary clinical sign and patient-reported symptom endpoint.

article thumbnail

China’s NMPA grants priority review status for Ocumension’s Zerviate NDA

Pharmaceutical Technology

Nicox’s Chinese partner Ocumension Therapeutics has secured priority review status for the New Drug Application (NDA) for Zerviate (cetirizine ophthalmic solution), 0.24%, from China’s National Medical Products Administration (NMPA). sales milestones along with royalties ranging between 5% and 9% of net sales of the solution by Ocumension.

Licensing 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Build a More Participant-Focused Trial: Amplify the Patient Voice in Clinical Research Technology Development

Fierce Pharma

Author: Mike Cioffi, Senior Vice President, Clinical Solutions and Strategic Development, WCG | Patients need to be involved in developing ePRO assessments from the outset, especially for endpoints without existing standards or scales. Ideally, sponsors

article thumbnail

CTTI Publication Investigates Challenges and Solutions Surrounding Digitally Derived Endpoint Acceptance

CTTI (Clinical Trials Transformation Initiative)

A new CTTI publication , published in Digital Biomarkers , investigates the challenges sponsors encounter when using digitally derived endpoints and offers potential solutions. The post CTTI Publication Investigates Challenges and Solutions Surrounding Digitally Derived Endpoint Acceptance appeared first on CTTI.

article thumbnail

ERT, Bioclinica merger unites clinical trial tech teams

Outsourcing Pharma

The combination of companies brings together ERTâs clinical endpoint data capabilities and Bioclinicaâs imaging, eClinical and drug-safety solutions.

article thumbnail

Comparative Perspectives: Unveiling the Nuances Between Veterinary and Human Clinical Trials

Cloudbyz

Veterinary clinical trials and human clinical trials share some similarities, but there are key differences owing to the distinct nature of the subjects involved—animals versus humans. Human Trials: Human clinical trials primarily use coding systems that are specific to human medical conditions and interventions.

article thumbnail

Seizure Disorder eDiary

WCG Clinical

Related Topics Clinical Trial Operational Excellence Clinical Endpoint Solutions Videos Most Recent Posts Why Biotech Sponsors Need Outside Support: IRB, IBC, DMCs and EACs More Guidance, Less Variability: Digital EDSS Givers Raters a More Precise, More User-Friendly Tool for MS Assessments Improving Research Billing Outcomes: The Real Impact of Coverage (..)